Back

American Association for the Study of Liver Diseases

  • Carcinoma, Hepatocellular
  • Hepatitis B
  • Hepatitis B, Chronic

Guideline Update: Practice Guideline of Chronic Hepatitis B

This presentation describes the updates to the recently published 2025 treatment guidelines for Hepatitis B (HBV). It will define goals of therapy when treating individuals with chronic HBV and outline management strategies for the various phases of infection, including the indeterminant phase. Updated recommendations concerning treating HBV in pregnancy, those in high-risk scenarios, and the immune tolerant phase will be reviewed. The latest guidance on treatment discontinuation and surveillance for hepatocellular carcinoma will be discussed. This presentation provides background to and will enhance understanding of the updated guidelines, emphasizing the application of disease monitoring and shared decision making in treating patients with chronic HBV infection.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Paid · fee on provider site

See fees on liverlearning.aasld.org

Listed by the provider

  • Online course / module
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Paid · fee on provider site
  • Released
    Nov 1, 2025
  • Last day to claim credit
    Nov 2, 2027 1 year left